(Q42730284)

5 November 2017

0 references

In vitro activity of rifaximin against enteropathogens producing traveler's diarrhea (English)

1 reference

5 November 2017

0 references

1 reference

J Ruiz

2

0 references

Jordi Vila

object named as

J Vila

5

0 references

author name string

J M Sierra

1

1 reference

5 November 2017

M M Navia

3

1 reference

5 November 2017

M Vargas

4

1 reference

5 November 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Antimicrobial Agents and Chemotherapy

5 November 2017

1 reference

5 November 2017

45

1 reference

5 November 2017

2

1 reference

In vitro activity and fecal concentration of rifaximin after oral administration

5 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90347

Tropical and exotic infections. Proceedings of the 5th Liverpool Tropical School Bayer Symposium on Microbial Diseases. 14 February 1998.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90347

Antimicrobial resistance of diarrheagenic Escherichia coli isolated from children under the age of 5 years from Ifakara, Tanzania.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90347

The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90347

Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90347

Campylobacter jejuni as a cause of traveler's diarrhea: clinical features and antimicrobial susceptibility.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90347

Etiology of traveller's diarrhea in Spanish travellers to developing countries

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90347

Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90347

Rifaximin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential in conditions mediated by gastrointestinal bacteria

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90347

In vitro antibacterial activity of rifaximin against Clostridium difficile, Campylobacter jejunii and Yersinia spp.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90347

Antimicrobial Resistance of Nontyphoidal Salmonella Isolates in Traveler's Diarrhea.

27 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=90347

10.1128/AAC.45.2.643-644.2001

16 August 2018

Identifiers

DOI

1 reference

5 November 2017

1 reference

5 November 2017

PubMed publication ID

11269233

1 reference